IQVIA Holdings | IQV - Selling And Administration Expenses


IQVIA Holdings reported $569M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Accenture USD 3.12B 162.33M Jun/2026
Agilent USD 475M 10M Jun/2026
Bruker USD 226.5M 12.4M Sep/2026
Cardinal Health USD 1.6B 30M Sep/2026
Celltrion KRW 12.72B 3.4B Jun/2026
Charles River Laboratories USD 140.59M 88.31M Sep/2026
Cigna USD 3.61B 142M Sep/2026
Cognizant Technology Solutions USD 841M 32M Sep/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Danaher USD 2.16B 87M Sep/2026
Dentsply International USD 363M 1000K Sep/2026
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 13.56M 1.09M Jun/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Elevance Health USD 10.91B 309M Dec/2025
Humana USD 3.36B 614M Mar/2025
IBM USD 5.05B 516M Sep/2026
Illumina USD 281M 8M Sep/2026
Infosys INR 49.07B 41.54B Sep/2026
Kangmei Pharma CNY 253.72M 16.66M Jun/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Laboratory Of America USD 611.4M 34.2M Sep/2026
Malin Corporation EUR 1.1M 400K Dec/2024
McKesson USD 2.27B 5M Sep/2026
Mettler Toledo International USD 267.16M 3.82M Sep/2026
Organigram Holdings CAD 26.51M 4.5M Jun/2026
Ovoca Bio EUR 617K 15K Dec/2025
Pharma Mar EUR 15.53M 1.59M Sep/2026
Qiagen NV USD 142.33M 60K Jun/2026
Quest Diagnostics USD 523M 6M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
Sartorius EUR 216.6M 4.7M Sep/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Tilray USD 24.85M 1.7M Sep/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Veeva Systems USD 138.88M 12.4M Jun/2026
Veradigm USD 27.28M 5.24M Dec/2022
Waters USD 398M 7M Sep/2026
Zealand Pharma A/S 104M 12.19M Mar/2026
Zz Pientze Pharmaceu CNY 267.85M 44.71M Sep/2026